Your browser doesn't support javascript.
loading
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial.
Fu, Qihan; Zheng, Yi; Fang, Weijia; Zhao, Qingwei; Zhao, Peng; Liu, Lulu; Zhai, You; Tong, Zhou; Zhang, Hangyu; Lin, Meihua; Zhu, Xudong; Wang, Huamao; Wang, Yumeng; Liu, Zhen; Yuan, Daijing; Bao, Xuanwen; Gao, Wanwan; Dai, Xiaomeng; Li, Zonghai; Liang, Tingbo.
Afiliación
  • Fu Q; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zheng Y; Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, China.
  • Fang W; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Zhao Q; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhao P; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Liu L; Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, China.
  • Zhai Y; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Tong Z; Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
  • Zhang H; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Lin M; Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, China.
  • Zhu X; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wang H; Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
  • Wang Y; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Liu Z; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Yuan D; Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
  • Bao X; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Gao W; CARsgen Therapeutics Ltd., Shanghai, China.
  • Dai X; CARsgen Therapeutics Ltd., Shanghai, China.
  • Li Z; CARsgen Therapeutics Ltd., Shanghai, China.
  • Liang T; CARsgen Therapeutics Ltd., Shanghai, China.
EClinicalMedicine ; 63: 102175, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37680942
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: EClinicalMedicine Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: EClinicalMedicine Año: 2023 Tipo del documento: Article